Gerald Hengstman

Gerald Hengstman

Neurology

149 Bosscheweg
Boxtel, NB 5282 WV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

Journal: NEJM evidence

Published: November 10, 2025

Subjective cognitive impairment is related to work status in people with multiple sclerosis.

Subjective cognitive impairment is related to work status in people with multiple sclerosis.

Journal: IBRO neuroscience reports

Published: July 27, 2022

Self-reported work productivity in people with multiple sclerosis and its association with mental and physical health.

Self-reported work productivity in people with multiple sclerosis and its association with mental and physical health.

Journal: Disability and rehabilitation

Published: October 05, 2021

Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter?

Self-reported occupational functioning in persons with relapsing-remitting multiple sclerosis: Does personality matter?

Journal: Journal of the neurological sciences

Published: February 17, 2021

Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.

Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report.

Journal: Multiple sclerosis and related disorders

Published: May 18, 2020

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.

Journal: Applied health economics and health policy

Published: January 16, 2020

A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis.

A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis.

Journal: Disability and rehabilitation

Published: November 09, 2019

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands.

Journal: Applied health economics and health policy

Published: August 25, 2019

Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis.

Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: July 10, 2018

The capability set for work - correlates of sustainable employability in workers with multiple sclerosis.

The capability set for work - correlates of sustainable employability in workers with multiple sclerosis.

Journal: Health and quality of life outcomes

Published: January 31, 2018

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.

Journal: Trials

Published: September 13, 2013

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.

Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.

Journal: BMC neurology

Published: August 10, 2013

Showing 1-12 of 34

Last Updated: 09/26/2026